Mika Lindroos, Director of Product Management at CRF Health, discusses the advantages of electronic informed consent in clinical trials and how by integrating this process with eCOA technologies, researchers can reduce burden for study teams, decrease regulatory risk, increase participant comprehension, and improve overall study outcomes. Courtesy of PharmaFocus (original link: http://edition.pagesuite-professional.co.uk/launch.aspx?eid=b3114258-2357-4dee-b791-295cd1220624&pnum=18). Double click on the page to zoom in.
About the Author
Director of Product Management, CRF HealthMore Content by Mika Lindroos